Zoll Medical Corp. (ZOLL) Tops Q3 EPS by 7c; Guides FY11 EPS Growth

July 28, 2011 4:24 PM EDT
Zoll Medical Corp. (NASDAQ: ZOLL) reported Q3 EPS of $0.42, $0.07 better than the analyst estimate of $0.35. Revenue for the quarter came in at $136.2 million versus the consensus estimate of $129.97 million.

Sees FY11 EPS in mi-$1.30's. Consensus sees EPS of $1.27.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Earnings, Guidance